Cytex Therapeutics, Inc.
Biotechnology company · Durham, North Carolina, United States
Cytex Therapeutics, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. It has received 21 US government small-business research awards (SBIR/STTR) from health agencies, $18 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $125,000 sold in a notice filed in 2025.
Cytex Therapeutics at a glance
What does Cytex Therapeutics do?
US government research funding
21 SBIR/STTR small-business research awards from US health agencies, $18.1 million in total (2007 to 2023). NIH funding came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $125,000 sold (2025).
Frequently asked questions about Cytex Therapeutics
Where is Cytex Therapeutics headquartered?
Cytex Therapeutics, Inc. is headquartered in Durham, North Carolina, United States.
What does Cytex Therapeutics do?
Cytex Therapeutics, Inc. is a biotechnology company.
Similar companies
- Humacyte, Inc.Durham, North Carolina, United States
- Precision Biosciences IncDurham, North Carolina, United States
- Xilis, Inc.Durham, North Carolina, United States
- inSoma Bio, Inc.Durham, North Carolina, United States
- Atsena Therapeutics, Inc.Durham, North Carolina, United States
- Scion Neurostim, Inc.Durham, North Carolina, United States
- Sapere Bio, Inc.Durham, North Carolina, United States
- BioAesthetics CorpDurham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences